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Abstract
Background: The ventral midbrain contains a diverse array of neurons, including dopaminergic neurons of the
ventral tegmental area (VTA) and substantia nigra (SN) and neurons of the red nucleus (RN). Dopaminergic and RN
neurons have been shown to arise from ventral mesencephalic precursors that express Sonic Hedgehog (Shh).
However, Shh expression, which is initially confined to the mesencephalic ventral midline, expands laterally and is
then downregulated in the ventral midline. In contrast, expression of the Hedgehog target gene Gli1 initiates in
the ventral midline prior to Shh expression, but after the onset of Shh expression it is expressed in precursors
lateral to Shh-positive cells. Given these dynamic gene expression patterns, Shh and Gli1 expression could delineate
different progenitor populations at distinct embryonic time points.
Results: We employed genetic inducible fate mapping (GIFM) to investigate whether precursors that express Shh
(Shh-GIFM) or transduce Shh signaling (Gli1-GIFM) at different time points give rise to different ventral midbrain
cell types. We find that precursors restricted to the ventral midline are labeled at embryonic day (E)7.5 with Gli1-
GIFM, and with Shh-GIFM at E8.5. These precursors give rise to all subtypes of midbrain dopaminergic neurons and
the anterior RN. A broader domain of progenitors that includes the ventral midline is marked with Gli1-GIFM at
E8.5 and with Shh-GIFM at E9.5; these fate-mapped cells also contribute to all midbrain dopaminergic subtypes
and to the entire RN. In contrast, a lateral progenitor domain that is labeled with Gli1-GIFM at E9.5 and with Shh-
GIFM at E11.5 has a markedly reduced potential to give rise to the RN and to SN dopaminergic neurons, and
preferentially gives rise to the ventral-medial VTA. In addition, cells derived from Shh- and Gli1-expressing
progenitors located outside of the ventral midline give rise to astrocytes.
Conclusions: We define a ventral midbrain precursor map based on the timing of Gli1 and Shh expression, and
suggest that the diversity of midbrain dopaminergic neurons is at least partially determined during their precursor
stage when their medial-lateral position, differential gene expression and the time when they leave the ventricular
zone influence their fate decisions.
Background
The ventral mesencephalic progenitor domain gener-
ates a diverse array of distinct neuronal cell types,
including neurons of the red nucleus (RN), motoneur-
ons of the oculomotor nucleus and midbrain
dopaminergic (DA) neurons. DA neurons are further
organized into anatomically and functionally distinct
subclasses [1]. The substantia nigra (SN), located in
the lateral-ventral midbrain, projects to the dorsal-lat-
eral striatum and is involved in the regulation of
motor behaviors. The ventral tegmental area (VTA),
located more medially, projects to corticolimbic tar-
gets and is important for motivational states. The ret-
rorubral field is located posterior to the SN and
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functional diversity of these different regions becomes
apparent in disease states: in Parkinson’sd i s e a s e ,S N
neurons, but not VTA neurons, degenerate, resulting
in severe motor deficits. In contrast, abnormalities in
the mesocorticolimbic system have been implicated in
addiction, schizophrenia and attention deficit disorder
[2-4]. While it is well established that the functional
diversity of ventral midbrain neurons and DA sub-
classes is based on their distinct efferent and afferent
connections and their distinct molecular make-up and
physiology, it remains unclear when and how these
distinct neuronal (sub)classes are established during
development.
All midbrain DA neurons appear to arise from ventral
mesencephalic floor plate progenitors that express Sonic
Hedgehog (Shh) [5-8]. A recent paper utilizing genetic
inducible fate mapping (GIFM) [9] suggested that Shh
expression between embryonic day (E)7.5 and E12.5
sequentially marks three spatially distinct ventral mesen-
cephalic progenitor domains that give rise to different
neurons. However, the distribution of fate-mapped cells
was only assessed qualitatively at embryonic stages, and
a potential contribution to glia was not determined.
Gli1, a zinc finger transcription factor in the Shh
signaling pathway, is only transcribed in cells that
receive high levels of Hedgehog signaling (and are close
to the source of Hedgehog) [10,11]; therefore, its expres-
sion can be used as a readout for cells that are exposed
to high levels of Shh signaling [12]. Shh-expressing cells,
including the floor plate cells themselves, do not
respond to Shh signaling as measured by the expression
of Gli1 [11-13]. It is therefore necessary to understand
the exact timing of Shh responses and Shh expression in
ventral midbrain precursors to gain a better insight into
the role of Shh signaling in specification of ventral mid-
brain neurons.
To establish a precise precursor map of the ventral
mesencephalon, we assessed the fate of Gli1-expressing
(Shh-responding) and Shh-expressing progenitors with
GIFM in a quantitative manner at embryonic and post-
natal stages. We show that Gli1 expression precedes
Shh expression by about a day and demonstrate that
ventral midbrain precursors that give rise to DA neu-
rons respond to Shh signaling between E7.5 and E9.5
and express Shh between E8.5 and E11.5. Progenitors in
the ventral midline that are labeled with Gli1-GIFM at
E 7 . 5a n dw i t hS h h - G I F Ma tE 8 . 0t oE 8 . 5c o n t r i b u t et o
midbrain DA neurons and the anterior RN. Progenitors
in a broader domain are marked with Gli1-GIFM at
E8.5 and Shh-GIFM at E9.5 to E10.5 and show a strong
contribution to all subsets of DA neurons and to RN
neurons. Precursors adjacent to the ventral midline that
are fate-mapped with Gli1-GIFM at E9.5 and Shh-GIFM
at E11.5 maintain the potential to develop into DA
neurons of the ventral-medial VTA. However, they con-
tribute few cells to DA neurons in the SN and to RN
neurons. In addition, precursors labeled with Gli1-GIFM
at E8.5 to E9.5 give rise to other ventral midbrain
neurons, including neurons in the oculomotor nucleus
and the non-DA neurons in the SN reticularis, consis-
tent with a broad medial-lateral distribution of
Gli -expressing precursors. Finally, we observe that
Shh-a n dGli1-expressing progenitors, with the excep-
tion of progenitors in the ventral midline, develop into
ventral midbrain astrocytes.
Materials and methods
Fate mapping
Animal studies were performed under an approved
Institutional Animal Care and Use Committee animal
protocol according to the institutional guidelines at
Memorial-Sloan Kettering Cancer Center or were
a p p r o v e db yt h eU n i v e r s i t yo fB o n nA n i m a lC a r ea n d
Use Committee. ROSA
loxP-STOP-loxP-LacZ (R26
lz)r e p o r t e r
mice were kindly provided by Dr P Soriano [14]; ROSA-
loxP-STOP-loxP-EYFP (R26
EYFP)m i c ew e r ek i n d l yp r o v i d e d
by Dr F Costantini [15]; Shh
CreERneo mice (previously
called Shh
CreERT2 [ 9 , 1 6 ] )w e r ek i n d l yp r o v i d e db yD rC
Tabin. The neo cassette in the Shh
CreERneo allele was
deleted with an ACTB-Flpe deleter line [17] and only
mice without the neo cassette (referred to as Shh
CreER
mice) were used for fate mapping experiments. The
Gli1
CreER mice without neo were described previously
[12]. Mice heterozygous for the R26
lz or R26
EYFP allele
and the CreER alleles were genotyped as previously
described [14,18]. All mice were maintained in an
outbred SW or CD1 background. Shh
CreER/+R26
lz/lz,
Shh
CreER/+R26
EYFP/EYFP, Gli1
CreER/+R26
lz/lz or Gli1
CreER/
+R26
EYFP/EYFP males were bred with SW or CD1 wild-
type females (Taconic, Hudson, NY, USA or Charles
River, Wilmington, MA, USA) to generate Shh
CreER/
+R26
lz/+, Shh
CreER/+R26
EYFP/+, Gli1
CreER/+R26
lz/+ or
Gli1
CreER/+R26
YFP/+ progeny. Noon of the day that a
vaginal plug was detected was designated as E0.5.
Tamoxifen (TM; T-5648 Sigma, St. Louis MO, USA)
was dissolved in corn oil (Sigma C-8267) at a final con-
centration of 20 mg/ml. Pregnant females were given 3
to 4 mg TM through oral gavage with animal feeding
needles (Fisher Scientific, Waltham, MA, USA and Fine
Science Tools, Heidelberg, Germany) at 12 pm for
GIFM between E6.5 and E12.5 or at midnight for GIFM
at E8.0. For the analysis of fate-mapped cells at postna-
tal stages, the TM solution contained progesterone
(Sigma P-0130) at a concentration of 5 mg/ml to reduce
the incidence of miscarriages.
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Page 2 of 19Tissue processing, RNA in situ hybridization and
immunofluorescence stainings
Embryos or embryonic brains were dissected and fixed
in 4% paraformaldehyde for 20 to 90 minutes. Postnatal
day (P)14 to P60 mice were perfused intracardially with
4% paraformaldehyde, and brains were dissected and
postfixed in 4% paraformaldehyde overnight. E8.5 to
E14.5 embryos or embryonic brains were sectioned on a
cryostat at 12 μm, E18.5 brains at 14 μma n dp o s t n a t a l
brains at 40 μm (free-floating sections). For RNA in situ
hybridization, frozen sections were used or the tissue
was processed manually or in a Leica tissue processor
for paraffin embedding and sectioned at 7 μm. RNA in
situ hybridization was performed as described [19]. X-
gal and immunofluorescent stainings were performed
using standard procedures [19]. Primary antibodies: goat
anti-b-galactosidase (b-gal; 1:2,000, AbD Serotec,
Oxford, UK), rabbit or rat anti-GFP (1:400, Invitrogen,
Carlsbad, CA, USA or 1:2,000, Nacalai, Kyoto, Japan)
rabbit or mouse anti-tyrosine hydroxylase (TH; 1:500,
Millipore, Billerica, MA, USA), rabbit anti-Calbindin
(1:5,000, Swant, Marly, Switzerland), rabbit anti-Lmx1a
(1:2,000, Millipore), mouse anti-Pou4f1 (1:100, Santa
Cruz Antibodies, Santa Cruz, CA, USA), rabbit anti-glial
fibrillary acidic protein (GFAP; 1:500, Millipore), mouse
anti-glutamine synthetase (1:500, Millipore) and rabbit
anti-Girk2 (1:100, Alomone Labs, Jerusalem, Israel). The
mouse anti-Islet1 (Isl1, 1:50) and anti Nkx2-2 antibody
(1:50) developed by T Jessell and S Brenner-Morton and
the mouse anti-Nkx6-1 antibody (1:100) developed by
OD Madsen were obtained from the Developmental
Studies Hybridoma Bank. For Brn3a, Isl1, Lmx1a, Nkx2-
2 and Nkx6-1, sections were incubated in 0.1 mM
EDTA for 10 minutes at 65°C prior to the immunostain-
ings. Secondary antibodies: donkey anti-goat IgG-Alexa
555 and donkey anti-rabbit IgG-Alexa 488 (1:500; Invi-
trogen); donkey anti-goat Cy3, donkey anti-rabbit Cy3
or fluorescein isothiocyanate (FITC), donkey anti-mouse
Cy3 or FITC (1:200, Jackson ImmunoResearch, West
G r o v e ,P A ,U S A ) .I s l 1 ,N k x 2 - 2a n dN k x 6 - 1w e r e
detected with donkey-anti mouse biotin secondary anti-
body (1:200, Jackson ImmunoResearch), followed by
Cy3- or dichlorotriazinylaminofluorescein (DTAF)-
labeled streptavidin (1:1,000, Jackson ImmunoResearch).
Quantification
For the quantification of fate-mapped cells at E18.5, at a
minimum every tenth section was stained with b-gal
antibody and antibodies against markers of ventral mid-
brain neurons (TH, Pou4f1, Isl1). Sections containing
midbrain DA, RN or motoneurons were selected and
the entire area containing the neurons of interest was
photographed using a 20 × objective. To assess double
labeling, Z-stacks were taken and subjected to
deconvolution (Volocity Software, Perkin Elmer,
Waltham, USA). To cover the entire area, single pictures
were taken on a Leica DM6000 microscope (Leica
Microsystems, Wetzlar, Germany) and stitched together
in Photoshop (Adobe Systems Inc.). Alternatively, a sin-
gle optical section of the area was imaged with a Zeiss
Axio observer microscope using Mosaix software and an
Apotome setup (Axiovision, Zeiss, Oberkochen, Ger-
many). Cells positive for both the neuronal marker and
b-gal were counted. Sections were counted from at least
t h r e ea n i m a l s .A tl e a s tf o u r( T H )o ra tl e a s tt h r e es e c -
tions (Pou4f1) were counted per animal. The average
number of double-labeled cells per section was deter-
mined for each animal. The values presented are the
average values of three to five animals. Significance (at P
< 0.05) was determined using Student’s t-test. For the
regional quantification, sections from four rostral-caudal
DA-neuron-containing midbrain regions were selected
based on the anatomy of the TH-positive nuclei in the
ventral midbrain. The number of cells in each region
was normalized for the number of sections counted.
The values presented are the average values of at least
three animals. Significance (at P < 0.05) was determined
by analysis of variance (ANOVA) and least significant
difference (LSD) post-hoc analysis.
For the quantification of the overall distribution of DA
neurons and of DA neurons labeled with Shh- or Gli1-
GIFM in postnatal brains, sections at four rostral-caudal
levels (approximately Bregma -2.92, Bregma -3.18,
Bregma -3.40, Bregma -3.64) were picked from at least
three animals for each time point. Sections were imaged
on a Zeiss Axio observer using the Zeiss Mosaix soft-
ware and an Apotome setup to assess double labeling
(Axiovision, Zeiss). For each level, the areas containing
TH-positive DA neurons were outlined [20] and the
number of b-gal- and TH-positive or enhanced yellow
fluorescent protein (EYFP)- and TH-positive cells
located in the SN, dorsal-lateral VTA (dlVTA) and ven-
tral-medial VTA (vmVTA) was determined. If more
than one section was counted per level, numbers were
averaged for the number of evaluated sections. Signifi-
cance (at P < 0.05) was determined by ANOVA and
LSD post-hoc analysis or Student’s t-test.
Results
The Shh expression domain in the ventral mesencephalon
undergoes a medial to lateral shift during embryonic
development
We and others have previously shown that Shh expres-
sion is dynamic in the ventral midbrain [8,13,21-23]. We
investigated the temporally dynamic expression pattern
of Shh in the ventral midbrain precursor domain in
more detail by performing in situ hybridization analysis
of Shh mRNA on transverse (E8.5) or coronal sections
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Page 3 of 19(all other stages) of embryos each day between E8.5 and
E12.5. As previously described, we found that at E8.5,
Shh expression was restricted to a narrow medial
domain overlying the notochord, and the domain
expanded laterally until E10.5, when Shh expression
began to be downregulated in the medial domain
(Figure 1A-E). However, in contrast to previous studies
[8,23], weak Shh expression was detected in the medial
domain at E11.5 and E12.5. In comparison to Shh,t h e
expression of Lmx1a, a putative marker of the DA pre-
cursor domain, which is first expressed in the ventral
midbrain at E9.0, was found to have a less dynamic
expression pattern and was restricted to a more medial
domain [23] (Figure 1K-N).
The location of Gli1-expressing (Shh-responding) ventral
mesencephalic precursors shifts laterally over time
Gli1 is initially expressed in the ventral midline of the
neural tube at E7.5 [24], suggesting that the ventral
mesencephalic neural tube receives high levels of Shh
signaling from the notochord at E7.5. We observed that
once Shh expression was present in ventral midline cells
(starting around E8.5), Gli1 expression was downregu-
lated in the Shh-expressing cells and was excluded from
the midline, indicating that Shh-expressing cells cease
responding to Shh signaling (Figure 1F-J) [13,22]. At
E8.5 and subsequent stages, Gli1 was expressed in
precursors adjacent to the Shh-expressing domain
(Figure 1F-J). At E9.5, there was some overlap between
Shh and Gli1 expression at their domain boundaries,
where both Gli1 and Shh w e r ee x p r e s s e da tl o wl e v e l s
and/or in a mosaic manner (Figure 1B’,G’ and data not
shown). At later stages the Gli1 and Shh expression
domains appeared to be clearly separated (Figure 1C,H,
D,I,E,J). Interestingly, Gli1 expression was not induced
in the medial domain after Shh expression was downre-
gulated at E10.5, perhaps because a low level of Shh
expression remained. In summary, we demonstrate that
there is a medial to lateral shift in the Shh and Gli1
expression domains between E8.5 and E12.5 in the ven-
tral mesencephalon. Gli1 expression is found lateral to
the Shh-expressing domain at all time points. Thus, the
time period when Shh and Gli1 are expressed in spa-
tially defined progenitor domains could potentially
delineate progenitor populations of different ventral
midbrain cell types.
Fate mapping strategy to follow the fate of progenitors
in different medial-lateral Shh- and Gli1-expressing
mesencephalic domains
To determine whether precursors in the temporally
different Shh-o rGli1-positive domains give rise to dis-
tinct (sub)classes of ventral midbrain neurons, we used
GIFM [25]. This technique provides temporal and spa-
tial control of cell marking by utilizing an inducible
form of site-specific recombinase, CreER and a reporter
allele, which permanently expresses a marker gene (for
example, lacZ, EYFP) after Cre-mediated recombination
[26]. Temporal control of marking is achieved by
administering TM at specific time points in develop-
ment to activate CreER. For our GIFM approach, we
used mouse lines in which a TM-inducible form of Cre
(CreERT2) is expressed by the Shh or Gli1 allele
(Shh
CreER or Gli1
CreER line) [12,16]. As nuclear translo-
cation of CreER occurs within 6 hours of TM
Figure 1 Dynamic changes in Shh and Gli1 expression in the
ventral mesencephalic neural tube. RNA in situ hybridization with
Shh, Gli1 and Lmx1a RNA probes. The analysis was performed on
transverse sections (E8.5) or coronal sections of the mesencephalon
(mes; E9.5 to E12.5); sections shown are at the level of the
intermediate mes. V, ventral; D, dorsal. The mesencephalon is
outlined. (A-E) Shh is initially expressed in the notochord (NC) and
is induced in the mesencephalon floor plate (FP) at E8.5. Shh
expression expands laterally over the subsequent days of
development (E9.5 to E12.5), but is downregulated medially (E10.5
to E12.5). (F-J) At all time points analyzed, Gli1 expression, a readout
for high levels of Shh signaling, is located laterally to the Shh-
expressing cells. Gli1 expression is largely absent in the Shh-
expressing domain, indicating that Shh-expressing cells do not
respond to high level Shh signaling. At E9.5, the weak ventral
expression domain of Gli1 and the weak lateral expression domain
of Shh appear to overlap partially (B’,G’, asterisks), but at later stages,
the Shh and Gli1 domains are clearly separated. Note that Gli1
expression is not upregulated in medial cells that downregulate Shh
expression. (K-N) Lmx1a is expressed in the DA precursor domain
and in differentiating DA neurons. Scale bars: (A,F) 50 μm; (B-E,G-J,K-
N) 100 μm.
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Page 4 of 19administration and is maintained for approximately 24
hours [22,27,28] cells expressing Shh and Gli1 at 6 to 36
hours after TM administration can be genetically
marked. The ubiquitously expressed ROSA
loxP-STOP-loxP-
LacZ (R26
lz)o rROSA
loxP-STOP-loxP-EYFP (R26
EYFP)a l l e l e s
[14,15] were used to permanently mark Shh-o rGli1-
expressing precursors at distinct developmental time
points and to track the fate of cells derived from the
genetically marked precursors. We refer to the time
point of TM injection as TM followed by the embryonic
day (for example, TM administration at E8.5 is TM8.5).
X-gal staining or immunohistochemistry for b-gal 24
hours after TM administration showed that the resultant
marking was mosaic (less than 100% of cells expressing
Shh or Gli1 were marked; compare Figures 1 and 2;
data not shown). In an initial GIFM study with the ori-
ginal Shh
CreERneo allele that contains an FRT-flanked neo
cassette downstream of CreER [16], we observed only a
few lacZ-positive cells in each section of the mesence-
phalon when administering 3 to 4 mg of TM (Addi-
tional file 1A-C and data not shown), making it very
difficult to investigate the fate of these cells in a quanti-
tative manner. Since we previously found that a neo cas-
sette can decrease CreER expression in knock-in alleles
with a similar design [29], we removed the neo cassette
with an ACTB-Flpe deleter line [17]. Using the new line
(Shh
CreER) for GIFM with the same dose of TM, we
found indeed many more lacZ-positive cells in the
mesencephalon (Additional file 1 and data not shown).
In general, we observed more overall recombination
with the Shh
CreER line than with the Gli1
CreER line
(Figures 2 and 3; Additional file 2). The lower recombi-
nation efficiency of the Gli1
CreER line is likely due to
overall lower expression levels of Gli1 (and therefore
CreER). Alternatively, Gli1 could be expressed at differ-
ent levels in subsets of cells with only some cells expres-
sing high enough levels of CreER to induce
recombination. Such a bias of GIFM towards marking of
cells with higher expression levels is inherent to the
technique. The spatial limits of the domains of mosaic
marking in animals that received TM at the same time
point and were analyzed at the same developmental
stage were very similar between animals for each Crier
allele, with variations only in the percentage of cells
marked (data not shown).
Shh and Gli1 expression define distinct precursor domains
in the ventral mesencephalon
As a first step in determining the fate of Shh-a n dGli1-
expressing ventral midbrain progenitors, we confirmed
that the fate-mapped domains corresponded to the
observed mRNA expression patterns of Shh and Gli1.I n
addition, we assessed how the distribution of the Shh-
and Gli1-expressing precursor relates to other ventral
mesencephalic precursor markers. To this end, Shh- and
Gli1-expressing precursor cells marked at distinct time
points (between E7.5 and E12.5 for Shh-GIFM and
between E6.5 and E9.5 for Gli1-GIFM) were analyzed in
the embryonic ventral mesencephalon at E12.5, and at
E9.5 and E10.5 where applicable (Figures 2 and 3 and
data not shown). The distribution of fate-mapped cells
was compared with the expression of known ventral
midline markers using either immunofluorescence stain-
ing for EYFP and the relevant marker or RNA in situ
hybridization on adjacent sections (Figure 2 and data
n o ts h o w n ;A d d i t i o n a lf i l e2 ) .L m x 1 a ,C o r i na n dM s x 1
are putative markers for the DA precursor domain, but
Msx1 and Corin appear to be more medially restricted
than Lmx1a [23,30]. Nkx6-1 and Sim1 are putative mar-
kers for precursors of the RN and motoneurons. Foxa2
is expressed in the Lmx1a- and Nkx6-1-positive
domains. Nkx2-2 is a putative marker for precursors of
GABAergic neurons [23,31,32] (Figure 2; Additional file
3). To identify the nascent DA region at E12.5, b-gal
immunostaining for fate-mapped cells was combined
with staining for TH, a marker for DA neurons (Figure
3) [33].
Shh-GIFM with TM7.5 resulted in the labeling of cells
in the midline, but only in the anterior-most mesence-
phalon (data not shown). When marked with TM8.5
and analyzed at E9.5 and E10.5, cells derived from Shh-
expressing progenitors (hereafter referred to as Shh-
derived cells) were restricted to a narrow medial pro-
genitor domain nested within the Msx1/Corin/Lmx1a/
Foxa2-positive domain, with only a few anterior cells
overlapping with Nkx6-1 (n = 4; Figures 2A,B,D,K-M
and 3A,B and data not shown; Additional file 2I). Cells
marked with TM9.5 and analyzed at E10.5 or E12.5
were distributed over a broader ventral domain that was
nested within the Foxa2-positive domain and spanned
the Lmx1a/Msx1/Corin as well as most of the Nkx6-1/
Sim1-positive domains (n = 3; Figures 2A-E,N,O and
3C,D and data not shown; Additional file 2A,B,I). At
E10.5, the domain labeled with Shh-GIFM at E9.5
appeared to be more medially restricted than at E12.5.
This could be due to an incomplete recombination of
the reporter allele at E10.5 (24 hours after TM adminis-
tration). The medial-lateral extent of Shh-derived cells
was maintained with TM10.5, but fewer cells were
observed medially (n = 3; Figure 3E,F and data not
shown). With TM11.5 (analyzed at E12.5) and TM12.5
(analyzed at E13.5) only the more lateral cells were
labeled. These lateral precursors were located in the
Nkx6-1/Sim1/Foxa2 expressing domain and in the lat-
eral aspects of the Lmx1a-positive domain (n = 3; Fig-
ures 2F-J,P,Q and 3G,H and data not shown; Additional
file 2C,D,I). Since we observed weak medial expression
of Shh in our gene expression analysis at E11.5 and
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Page 5 of 19Figure 2 Initial domains of cells marked with Shh- or Gli1-GIFM in comparison with other ventral midbrain markers. (A-Y) In situ
hybridization (A-J) and immunostainings (K-Y) on E10.5 and E12.5 coronal sections for markers of the DA precursor domain (Lmx1a, Msx1, Corin)a n d
the RN precursor domain (Sim1, Nkx6-1). Foxa2 encompasses both precursor domains. Nkx2-2 labels a precursor domain that is thought to give rise to
GABAergic interneurons. (K-Y) Shh-GIFM (K-Q’) and Gli1-GIFM (R-Y’). TM was administered at the indicated time points and marked cells were analyzed
at E10.5 or E12.5 with EYFP (green) and Nkx6-1 or Nkx2-2 (red) immunostaining. The Lmx1a-expressing (yellow or orange dashed line) and the Foxa2-
expressing (blue dashed lines) cells are outlined in some sections. Arrows indicate double-labeled cells, arrowheads in X’ and Y’ indicate fate-mapped
cells in the Nkx6-1 negative medial domain. The medial-lateral extent of the initial fate-mapped domains reflects the endogenous gene expression
around the time of TM administration (compare with Figure 1). Note that the labeling is mosaic, since only a subset of cells is recombined in a given
domain. Panels (L’-Y’) are higher magnifications of the areas indicated with the dashed box in (L-Y). (Z) Distribution of cells fate-mapped at the
indicated time points. The summary is based on the immunostainings and in situ hybridizations at E10.5 and E12.5. To assess the distribution of the
fate-mapped cells, at least three sections were analyzed for each TM time point at E10.5 and E12.5. To determine the expression domains of the
specific transcription factors, sections from at least three embryos were analyzed. Scale bars: 100 μm.
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Page 6 of 19E12.5 (Figure 1D,E), the lack of medial labeling is likely
due to CreER expression levels being too low to induce
recombination of the reporter allele. The medial-lateral
extent of the domains changed only slightly along the
anterior-posterior axis of the developing mesencepha-
lon, except for fate mapping with TM8.5 when the
medial domain was even more narrowly restricted in
posterior areas (Figure 3A,B). Finally, analysis at E12.5
showed that Shh-expressing progenitors marked with
GIFM between E8.5 and E11.5 overlapped with TH
expressing cells (Figure 3A-H and data not shown;
Additional file 2J).
GIFM of Gli1-expressing cells resulted in sparser
labeling than Shh-GIFM, indicating that only a small
number of cells that express Gli1 undergo recombina-
tion (compare Figure 2T and Figure 1F). Nevertheless,
analysis of several animals for each induction time point
allowed us to gain insight into the distribution of the
fate-mapped cells. Consistent with the mRNA expres-
sion pattern of Gli1, we found that initial marking of
Gli1-derived cells with TM6.5 produced a small number
of labeled cells in the ventral mesencephalic progenitor
zone (one to two cells per section) in a minority of
embryos (three of nine) (data not shown). With TM7.5,
Gli1-derived cells were mainly localized in a narrow
medial domain (Figures 2R,S and 3I,J), similar to the
domain occupied by Shh-derived cells labeled with
TM8.5, but a few cells were also found in the adjacent
Figure 3 Changing populations of precursors are marked with Shh- and Gli1-GIFM at different stages of development. (A-N)
Immunofluorescent staining for DA neurons (TH, green) and EYFP-positive fate-mapped cells (red) on E12.5 coronal sections of the
mesencephalon showing the distribution of marked cells in the ventricular zone and their contribution to TH-positive DA neurons. The labeling
is mosaic, since only a subset of cells is recombined in a given domain. Asterisks indicate a decreased contribution of marked cells to the medial
precursor domain. Arrowheads in (A) indicate TH/EYFP-positive cells that are located more lateral than their precursor domain. The
mesencephalon ventricle is outlined. v, ventral; d, dorsal. Note that there is less recombination with Gli1-GIFM (I-N) than with Shh-GIFM (A-K).
Scale bar: 100 μm. (O) The representative sections shown in (A-N) are at the level of the anterior and posterior mesencephalon as indicated in
the schematic. (P) Schematic of fate mapping strategy.
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Page 7 of 19Nkx6-1 domain (n = 3; Figure 2R,S). With TM8.5, the
Gli1-derived cells covered a broader ventral domain
(Figures 2T,U and 3K,L; Additional file 2E,F,K), with
less cells observed medially and some marked cells
located in the Nkx2-2-positive domain (n = 4; Figure
2T,U). With TM9.5, Gli1-derived cells were located in a
lateral domain (Figures 2V-Y and 3M,N; Additional file
2 G , H , K )t h a to v e r l a p p e dw i t ht h eN k x 2 - 2 - p o s i t i v e
domain and the lateral edges of the Lmx1a/Foxa2-posi-
tive domain in posterior sections. Marked cells were lar-
gely excluded from the Lmx1a-expressing domain in the
anterior midbrain (n = 3; Figures 2A-E,V,W and 3M;
Additional file 2G,K).
The analysis of Shh- and Gli1-derived precursors at
E12.5 allowed us to assess whether the dynamic changes
in the Shh and Gli1 gene expression domain were due
to lateral expansion of proliferating precursor cells or to
new populations of precursors expressing Shh and Gli1
at different stages of development. If the changes in Shh
expression are due to an expansion of cells initially
located medially, fate mapping of cells marked at early
(E8.5, medial domain) or later (E9.5, broad domain, and
E11.5, lateral domain) time points should result in iden-
tical progenitor domains at E12.5. If instead the changes
in gene expression are due to more laterally located pro-
genitor cells gradually switching on Shh or Gli1 expres-
sion (and medially located precursors switching off Shh
or Gli1 expression), distinct domains should be seen at
E12.5 following TM administration at different time
points. In line with the second model, the fate-mapped
(EYFP-positive) Shh-derived progenitors in the E12.5
ventral neural tube were located in distinct medial-lat-
eral domains depending on the time point of TM
administration. This was also the case for Gli1-derived
cells (Figure 3).
In summary, our analysis at several embryonic time
points shows that our GIFM approach faithfully marks
Shh-a n dGli1-expressing progenitor domains. Further-
more, the data demonstrate that during ventral midbrain
development, Gli1 expression precedes Shh expression
and that medial and medial-lateral ventral precursors
that initially express Gli1 switch to expressing Shh.I n
addition, we demonstrate that on each embryonic day
between E7 and E13, spatially distinct domains of pre-
cursors can be marked with Shh- or Gli1-GIFM (Figures
2 and 3). Four progenitor domains can be defined in the
ventral midbrain based on combinations of gene expres-
sion. They correlate in the following manner with the
Shh and Gli1 fate map (Figure 2Z; Additional file 3): a
medial domain (domain 1) positive for Lmx1a, Foxa2,
Corin and Msx1 that is marked with Gli1-GIFM at E7.5
t oE 8 . 5a n dw i t hS h h - G I F Ma tE 8 . 5t oE 1 0 . 5 ;ap a r a -
medial domain (domain 2) positive for Lmx1a and
Foxa2 that is sequentially labeled with Gli1-GIFM (at
E8.5 and in posterior sections also at E9.5) and with
Shh-GIFM (E9.5 to E12.5); a medial-lateral domain
(domain 3) positive for Foxa2, Sim1 and Nkx6-1 that is
first labeled with Gli1-GIFM (at E8.5 and in posterior
sections also at E9.5) and then with Shh-GIFM (E9.5 to
E12.5); and a Nkx2-2-positive lateral domain (domain 4)
that is only marked with Gli1-GIFM after E8.5.
Progenitors expressing Shh between E8.5 and E12.5 give
rise to dopaminergic and red nucleus neurons
To investigate in a quantitative manner which neuronal
subclasses develop from Shh-expressing precursors from
different medial-lateral domains, we fate mapped Shh-
expressing progenitors at different time points and ana-
lyzed the marked cells at E18.5 (Figure 4). Immunostain-
ing for b-gal and TH showed that Shh-derived cells
contributed to DA neurons with TM8.0 to TM12.5 (Fig-
ure 4A-F and data not shown). In contrast, with TM7.5,
only a very small number of scattered cells expressed b-
gal in the ventral midbrain, of which only rare cells
were double-labeled with TH (data not shown). Quanti-
tative analysis of the fate of progenitors marked at dif-
ferent time points demonstrated that the peak
contribution of Shh-expressing cells to DA neurons was
with TM9.5 (labeling at E10 to E10.5; Figure 4J). This
peak contribution correlates with the time point of most
extensive marking of Shh-expressing cells within the
Lmx1a-positive putative DA precursor domain (Figure
2; Additional file 2). Next we analyzed whether the fate-
mapped b-gal-positive cells expressed Pou4f1, a marker
for neurons of the RN. We found contribution to the
neurons of the RN with TM8.0 to TM11.5, but observed
a high contribution to the RN only with TM9.5 and
TM10.5 (Figure 4K). With TM8.0, the contribution to
Pou4f1-positive RN neurons was largely restricted to the
anterior RN (data not shown), consistent with our
observation that at E10.5 only a few TM8.5 Shh-derived
precursors expressed Nkx6-1 (Figure 2L,L’). The minor
contribution of Shh-expressing progenitors to RN neu-
rons after E11.5 is likely due to RN neurogenesis ceasing
before recombination (marking) occurs in the ventricu-
lar zone [31]. We did not detect any overlap of fate-
mapped cells with Islet1-expressing motoneurons of the
oculomotor nucleus (data not shown), likely because
motoneurons are born before Shh expression extends
into the Nkx6-1-positive motoneuron precursor zone
[31]. Furthermore, b-gal-positive neurons were never
found in the area of the SN reticularis, which is located
ventral to the SN, indicating that Shh-derived cells do
n o tc o n t r i b u t et ot h eG A B A e r g i cn e u r o n so ft h eS N
reticularis (Figures 5A and 6E-H and data not shown).
In summary, we demonstrate that Shh-expressing
mesencephalic progenitors give rise to DA neurons
between E8.5 and E12.5 and to RN neurons between
Blaess et al. Neural Development 2011, 6:29
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Page 8 of 19E8.5 and E10.5. The highest contribution to DA neurons
occurs at the time point when Shh is expressed through-
out the Lmx1a-positive DA precursor domain. We
further observed that the highest contribution to RN
neurons, which are likely derived from Nkx6-1 expres-
sing precursors, occurs after the expansion of Shh
expression into the Nkx6-1-positive domain.
Progenitors expressing Gli1 between E7.5 and E9.5 give
rise to dopaminergic and red nucleus neurons
To investigate the contribution of Shh-responding ven-
tral mesencephalic progenitors to different midbrain
neurons, we marked these domains at earlier time
points using Gli1-GIFM. Gli1-expressing progenitors
gave rise to DA and RN neurons when marked with
TM at E7.5, E8.5 and E9.5, with the highest contribution
observed with TM8.5 (Figure 4L,M). We observed, how-
ever, a much lower number of fate-mapped cells that
overlapped with DA or RN neurons than with Shh-
GIFM, consistent with the low recombination efficiency
of the Gli1
CreER allele observed in the ventral midbrain
precursor domain (Figures 2 and 3; Additional file 2). In
addition to RN and DA neurons, motoneurons of the
oculomotor nucleus were derived from Gli1-expressing
precursors with TM8.5 (data not shown), consistent
with Gli1 being expressed in the Nkx6-1-positive moto-
neuron precursor zone before motoneuron differentia-
tion [31]. Marking with TM9.5 and TM10.5 resulted in
the labeling of TH-negative cells within the SN and cells
in the SN reticularis (Figure 7E-G and data not shown).
This is in accordance with the observation that
Gli1-GIFM at E9.5 and E10.5 results in the marking of
Gli1-derived precursors in the Nkx2-2-positive precur-
sor domain (Figure 2V,X and data not shown). In con-
clusion, the contribution of Gli1-derived cells to DA
(and RN neurons) was earlier than that of Shh-derived
cells (Gli1-GIFM, TM7.5 to TM9.5; Shh-GIFM, TM8.0
to TM11.5), consistent with the dynamic and sequential
Shh and Gli1 gene expression patterns in the ventral
mesencephalon. Furthermore, Gli1-derived cells contrib-
uted to a wider array of ventral midbrain cell types, con-
sistent with the earlier and broader expression of Gli1 in
the ventral midbrain precursor domain.
The potential of Shh-expressing progenitors to contribute
to different groups of dopaminergic neurons changes
over time
Since DA neurons of the ventral midbrain are organized
into several anatomically and functionally distinct sub-
classes [1], we next asked whether a differential tem-
poral-spatial origin of DA neurons might correspond to
a preferential localization in specific DA nuclei. We first
Figure 4 Progenitors marked with Shh- and Gli1-GIFM give rise
to DA and RN neurons over several days of embryonic
development. (A-K) Shh-GIFM; (L,M) Gli1-GIFM. (A-F)
Immunofluorescent staining for DA neurons (TH, green) and b-gal-
positive fate-mapped cells (red) on E18.5 coronal sections. Examples
shown are located in the SN or the VTA. Arrows indicate double-
labeled cells. Note that there are distinct contributions of marked
cells to the SN or VTA at different fate-mapping time points. (G-I’)
Immunofluorescent staining for RN neurons (Pou4f1, green) and b-
gal-positive fate-mapped cells (red) on E18.5 coronal sections.
Arrows indicate double-labeled cells. Scale bar: 20 μm. (J-M)
Quantification of the contribution of cells marked with Shh- or Gli1-
GIFM to DA and RN neurons. Analysis was performed at E18.5. Cells
positive for TH and b-gal (J,L) or Pou4f1 and b-gal (K,M) were
counted and normalized for the number of counted sections. The
peak contribution of cells marked with Shh-GIFM to DA neurons is
with TM9.5, and to RN neurons with TM9.5 and TM10.5. These TM
time points correlate with the broadest Shh-expressing domain. The
peak contributions of cells marked with Gli1-GIFM to DA and RN
neurons are one to two days earlier than observed for cells labeled
with Shh-GIFM, consistent with medial Gli1 expression preceding
Shh expression. Error bars indicate standard deviations; asterisks
indicate the P-value as determined by Student’s t-test (*P < 0.05; **P
< 0.01). (N) Schematic of fate mapping strategy.
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Page 9 of 19determined the fate of ventral midbrain progenitors
using Shh-GIFM, since the recombination efficiency was
higher and the medial-lateral domains at the initial time
points were more compact than with the Gli1-GIFM
approach. We divided the ventral midbrain into four
rostral-caudal regions, based on the presence of different
DA nuclei (Figure 5B). The most rostral region contains
SN and dlVTA neurons (region a), at slightly more cau-
dal levels DA neurons are distributed into SN, dlVTA
and vmVTA (region b), further caudally the retrorubral
field becomes visible (region c), and in the most caudal
sections DA neurons are organized into the retrorubral
field (region d). Figure 5A schematically shows represen-
tative sections of marked cells in rostral and intermedi-
ate regions (region a and b) at E18.5 for each time point
of TM administration. With TM8.0, Shh-derived cells
were mainly found in rostral regions whereas with
TM9.5 cells contributed to the entire rostral-caudal and
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Figure 5 Precursors labeled with Shh-GIFM at different time points contribute differentially to different rostral-caudal regions of DA
neurons. (A) Representative schematics of sections immunostained for TH and b-gal. b-gal- and TH-expressing cells (dark blue dots) and b-gal-
expressing cells negative for TH (dark blue circles) on rostral (region a) and intermediate (region b) coronal sections through the E18.5 ventral
midbrain. The DA neuron containing areas are outlined. Early (TM administration at E8.0 (TM8.0) to TM10.5) but not late Shh-GIFM (TM11.5 to
TM12.5) results in contribution to the rostral and lateral areas of the SN. Shh-derived cells with TM11.5 contribute primarily to caudal and medial
areas of the VTA. dlVTA, dorsal-lateral VTA; vmVTA, ventral-medial VTA. (B) Schematic of the regions used to quantify the contribution of fate-
mapped cells to DA neurons in a region-specific manner. RRF, retrorubral field. (C) Relative contribution of Shh-derived cells to different regions
of DA neurons along the rostral-caudal axis of the midbrain. For each animal (n ≥ 3), b-gal- and TH-co-expressing cells were counted in four
regions along the rostral-caudal axis of the ventral midbrain as indicated in (B) and normalized for the combined number of double-labeled cells
counted in the four regions (in percent). Error bars indicate standard deviation. Significance (*P < 0.05; **P < 0.01; ***P < 0.001) was determined
by analysis of variance (ANOVA) and least significant difference (LSD) post-hoc analysis.
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Page 10 of 19medial-lateral extent of the DA nuclei. With TM10.5,
the contribution shifted more caudally, and with
TM11.5, cells were distributed primarily in caudal and
medial regions.
To quantitatively assess the distribution of fate-
mapped cells marked at the different time points, b-gal
and TH double-labeled cells were counted in each
region and the relative and absolute contribution to
each region was determined (Figure 5C; Additional file
4A). The relative contribution is a measure for the con-
tribution of fate-mapped/TH-positive cells to a region
or area in relation to the total number of fate-mapped/
TH-positive cells counted (Figures 5C, 6I and 7J,L; see
Materials and methods for details). Since GIFM results
in random mosaic labeling of a subset of cells expressing
a particular gene and the recombination efficiency can
vary between animals and time points, this approach
provides an unbiased assessment of the contribution of
cells marked at different time points to different DA
nuclei. Comparing the fate of cells marked between E8.0
and E11.5, the quantitative analysis confirmed that there
was a continuous decrease in the relative contribution
of Shh-derived cells to the most rostral region (region
a). In contrast, there was a slight increase in the relative
contribution of Shh-derived cells to more caudal regions
(region c) when comparing TM10.5 with TM8.0 or
TM9.5 (Figure 5C and data not shown). This shift from
rostral to caudal was also evident when comparing the
actual number of Shh-derived cells giving rise to DA
neurons. Comparison of cells labeled with TM9.5 or
TM10.5 (the two time points with the highest number
of labeled cells), showed no significant changes in the
number of cells contributing to caudal regions (regions
b to d), but a significantly lower contribution of cells
labeled with TM10.5 to the most rostral region (region
a; Additional file 4A). These data indicate that the con-
tribution of Shh-derived cells to DA neurons shifts from
rostral to caudal when Shh-derived cells are marked at
progressively later stages.
To further investigate the changing potential of Shh-
derived cells to contribute to different midbrain DA
subgroups, we analyzed the distribution of cells labeled
between E8.5 and E11.5 in postnatal brains (P21 to P30)
because the distinct anatomy of the different DA sub-
groups is more obvious at mature stages (Figure 6E-H,
L). We focused our analysis on the SN and VTA
because the subdivisions of the SN and VTA can be
clearly determined based on their location: the SN is
divided into the SN lateralis and SN pars compacta. The
VTA region is subdivided into the dorsal-lateral para-
brachial pigmented nucleus (referred to as dlVTA) and
the ventral-medial paranigral nucleus and interfascicular
nucleus (referred to as vmVTA; Figure 6E’,G’,L) [20]. To
assess the distribution of DA neurons within these three
areas, we counted all TH-positive neurons on sections
representative of different rostral-caudal levels of the
ventral midbrain and determined the relative number of
TH-positive neurons in SN, dlVTA and vmVTA. We
found that 52 .0 ± 2.0% of the DA neurons were located
in the SN, 33.2 ± 1.6% in the dlVTA and 14.8 ± 0.4% in
the vmVTA (n = 3; Additional file 4E,F). We next per-
formed a quantitative analysis of the relative contribu-
tion (the contribution of fate-mapped/TH-positive cells
to an area in relation to the total number of fate-
mapped/TH-positive cells counted) of Shh-derived cells
to DA neurons in the SN, dlVTA and vmVTA (see
Materials and methods for details). This analysis demon-
strated that with TM8.5 and TM9.5, about 60% of the
TH-positive Shh-derived neurons were located in the
SN (59.0 ± 3.4% and 62.6 ± 1.3%, respectively), about
30% in the dlVTA (32.8 ± 3.7% and 28.1 ± 2.8%, respec-
tively), and about 10% of Shh-derived DA neurons were
located in the vmVTA (6.6 ± 1.5% and 9.3 ± 2.4%,
respectively) (Figure 6I). Comparison of the relative con-
tributions of TH-positive neurons fate-mapped with
TM8.5 and TM9.5 and the distribution of DA neurons
to these three areas indicates that Shh-expressing cells
labeled with TM8.5 and TM9.5 have a slight bias to
contribute to the SN, but are underrepresented in the
vmVTA (Figure 6I; Additional file 4E). This biased con-
tribution is a rather surprising result for Shh-GIFM at
E9.5, since at this labeling time point the Lmx1a-posi-
tive DA precursor domain is labeled extensively (Figures
2N,O and Figure 3C,D). Interestingly, with TM10.5 and
TM11.5, the Shh-derived precursors had a markedly
reduced potential to contribute to the SN (38.1 ± 3.1%
and 14.1 ± 5.1%, respectively) and an increased potential
to contribute to the vmVTA (22.5 ± 7.1% and 54.3 ±
8.7%, respectively) when compared to cells fate-mapped
with TM8.5 or TM9.5 or when compared to the distri-
bution of DA neurons (Figure 6I; Additional file 4F).
To further test whether the increase in the relative
contribution to the vmVTA with TM11.5 is accompa-
nied by a decreased contribution to the SN, we quanti-
fied the number of fate-mapped cells that gave rise to
cells expressing Calbindin and Girk2. Calbindin is a cal-
cium binding protein primarily expressed in the VTA.
Girk2 is primarily expressed in the SN, but some posi-
tive cells are also found in the dlVTA (Figure 6J). When
we compared the ratio of cells contributing to Calbin-
din- versus Girk2-positive cells, we observed that
whereas with TM8.5 more cells contributed to Girk2
than to Calbindin-positive cells, the opposite was the
case with TM11.5 (Figure 6K).
To investigate whether the shift in competence of pre-
cursors expressing Shh after E10.5 (TM10.5 and
TM11.5) is due to an absolute decrease in cells contri-
buting to the SN and/or an absolute increase in the
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Page 11 of 19Figure 6 Cells labeled with Shh-GIFM at different time points have a changing potential to contribute to subpopulations of DA
neurons. (A-H) Immunofluorescent staining for b-gal-positive fate-mapped cells (Shh-GIFM at E8.5 or E11.5) and DA neurons (TH) on coronal
sections of the ventral midbrain (P21 to P30). The areas shown in (A-D) are indicated in (E-H). Arrows indicate double-labeled cells; arrowheads
indicate b-gal-positive cells with astrocytic morphology. (E’-H’) Representative schematics of the immunostained sections showing the
distribution of TH-positive fate-mapped cells (red dots) and of fate-mapped cells with astrocytic morphology (yellow crosses). Rostral, Bregma
-2.92; caudal, Bregma -3.40 [20]. If, interfascicular nucleus; Pn, paranigral nucleus; Snc, substantia nigra pars compacta; Snl, substantia nigra
lateralis; Vta, VTA. Fate-mapped cells outside these areas are not represented. Cells with astrocytic morphology are not present with TM8.5. Scale
bars: (A-D) 40 μm; (E-H) 200 μm. (I) Relative contribution of cells marked with Shh-GIFM between E8.5 and E11.5 to the SN (Snl + Snc), dorsal-
lateral VTA (Vta) and ventral-medial VTA (Pn + If); see schematic in (L). For each animal (n ≥ 3), TH-positive fate-mapped cells were counted in
the three indicated areas and normalized for the combined number of overlapping cells counted in these areas (in percent). Error bars indicate
standard deviation. Significance (*P < 0.05; **P < 0.01; ***P < 0.001) was determined by ANOVA and LSD post-hoc analysis. (J) Distribution of
Calbindin- and Girk2-positive cells. (K) Relative contribution of fate-mapped cells to Calbindin (VTA) versus Girk2 (SN) positive cells. Calbindin- or
Girk2-positive fate-mapped cells were counted in three different rostral-caudal midbrain areas (n ≥ 3). The ratio of Calbindin-positive fate-
mapped cells to Girk2-positive fate-mapped cells was determined. Significance (***P < 0.001) was determined by Student’s t-test. (L) Schematic
showing the SN, dlVTA and vmVTA. (M) Fate mapping strategy.
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Page 12 of 19number of cells contributing to the vmVTA, we also
compared the actual numbers of Shh-derived cells con-
tributing to the SN, dlVTA and vmVTA. This analysis
revealed that, compared to Shh-derived cells labeled
with TM9.5 (the peak contribution to DA neurons),
there was a significant decrease in the number of Shh-
derived cells giving rise to the SN and dlVTA with
TM11.5 (and with TM10.5 for the SN). This result is
not surprising when taking into account that the overall
contribution of Shh-derived cells to DA neurons is
much lower with TM11.5 than with TM9.5. Importantly,
however, the number of cells contributing to the
vmVTA did not change significantly when comparing
cells labeled with TM 9.5, TM10.5 and TM11.5 (Addi-
tional file 4C). In conclusion, these data indicate that
ventral midbrain precursors, which are located lateral to
the ventral midline and are labeled with Shh-GIFM after
E10.5, have a reduced potential to generate DA neurons
of the SN, but maintain the ability to give rise to the
vmVTA. In contrast, medial progenitors labeled with
Shh-GIFM at E8.5 and E9.5 can contribute to all DA
neuronal subpopulations.
The distinct developmental potential of precursors is not
solely due to different birthdates of dopaminergic neuron
subclasses
DA neurons are born between E10.5 and E14.5 in the
mouse according to [3H] thymidine birthdating studies
[34]. vmVTA neurons (interfascicular, paranigral) appear
to be born a day later (peak at E12.5) than SN or dlVTA
neurons (peak at E11.5). Moreover, rostral DA neurons
(peak at E11.5) are born before caudal DA neurons
(peak at E12.5) [34]. Therefore, the significant decrease
in the potential of Shh-derived cells to give rise to the
SN with TM10.5 and TM11.5 labeling (marking at E11
to E13) compared to cells labeled with TM8.5 and
TM9.5 might be due to the earlier birth date of SN neu-
rons. If most SN and dlVTA neurons are born before
E12.0, TM administration at E11.5 will selectively label
progenitors that give rise to the vmVTA, whereas TM
administration at E8.5 and E9.5 should label early and
late born DA neurons that give rise to all subpopula-
tions. Alternatively, the medial and lateral putative DA
precursor domains (domains 1 and 2, Figure 2Z) could
be intrinsically different, as supported by the molecularly
distinct medial domain that expresses Corin and Msx1
and ceases to respond to Shh earlier than the lateral DA
precursors. To investigate whether the medial-lateral
location of precursors might also contribute to different
progenitor fates, we took advantage of Gli1-GIFM, since
TM administration at E9.5 (labeling between E10 and
E11) marked Gli1-derived progenitors in a lateral
domain that included the posterior-lateral Lmx1a-posi-
tive domain (Figures 2X,Y and 3M,N; Additional file
2H). Since the labeling occurs a day before the majority
of SN and VTA neurons are born [34], a preferential
contribution of lateral Gli1-expressing progenitors to
t h ev m V T Aw o u l di n d i c a t et h a tt h e ya r ei n t r i n s i c a l l y
different from the other DA precursors. Indeed, analysis
of postnatal brains (P14 to P60) showed that with
TM9.5, the relative contribution of Gli1-derived cells to
the SN was significantly reduced compared to the nor-
mal distribution of DA neurons or compared to cells
fate-mapped with TM7.5 or TM8.5, whereas the relative
contribution to the vmVTA was significantly increased
with TM9.5 (Figure 7A-J and data not shown). When
we compared the actual numbers of Gli1-derived cells
contributing to the SN, dlVTA and vmVTA at each
stage, we also found that there was an increase in the
number of Gli1-derived cells giving rise to the vmVTA
with TM9.5 compared to TM7.5 and TM8.5, and a sig-
nificant decrease in the number of cells contributing to
the SN with TM9.5 compared to TM8.5 (Additional file
4D). In conclusion, these data provide strong evidence
that precursors, which are located lateral to the ventral
midline and continue to respond to Shh signaling after
E9.5 (Gli1-GIFM at E9.5), preferentially contribute to
the vmVTA.
Finally, we determined whether, similar to the change
in rostral-caudal distribution at E18.5 of cells marked
with Shh-GIFM, the rostral-caudal distribution of cells
labeled with Gli1-GIFM changed with different fate-
mapping time points. To this end, b-gal and TH dou-
ble-labeled cells were counted in four rostral-caudal
regions at E18.5 and the contribution to each region
was determined (Figure 7 L,M; Additional file 4B). As
expected, there was a decrease in the relative contribu-
tion of Gli1-derived cells to the most rostral region with
TM9.5 compared to TM7.5. In contrast, there was a
continuous increase in the relative contribution of Gli1-
expressing precursors to the most caudal region (region
d) with TM7.5 to TM9.5 (Figure 7L). This shift from
rostral to caudal contribution was also evident when the
actual number of Gli1-derived cells giving rise to DA
neurons was compared at E18.5 (Additional file 4B).
These data indicate that the contribution of Gli1-GIFM
cells to DA neurons shifts from rostral to caudal when
Gli1-derived cells are marked at progressively later
stages.
Shh- and Gli1-expressing lateral progenitors give rise to
astrocytes
In addition to uncovering the progressive temporal
change in the distribution of Shh-derived cells to DA
nuclei, we found that with Shh-GIFM at E9.5 to E11.5,
fate-mapped cells in the DA neuron containing areas
had distinct morphologies. In addition to neurons with
large, brightly labeled cell bodies and axonal projections
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Page 13 of 19Figure 7 Cells labeled with Gli1-GIFM at different time points have a changing potential to contribute to subpopulations of DA
neurons. (A-D) Representative schematics of immunostained sections (P14 to P60) labeled with Gli1-GIFM at E9.5. Red dots, TH-positive fate-
mapped cells; yellow crosses, cells with astrocytic morphology. Rostral, Bregma -2.92; caudal, Bregma -3.40 [20]. If, interfascicular nucleus; Pn,
paranigral nucleus; Snc, substantia nigra pars compacta; Snl, substantia nigra lateralis; Vta, VTA. (E-I’) Immunofluorescent staining for DA neurons
(TH, green) and fate-mapped cells (Gli1-GIFM at E9.5; b-gal, red) on coronal midbrain sections. The areas in (F,F’), (H,H’) and (I) are indicated in (E)
and (G). Big arrows indicate TH- and b-gal-positive cells; arrowheads indicate fate-mapped cells with astrocytic morphology; small arrows indicate
b-gal-positive, TH-negative cells with neuronal morphology. (I,I’) Z-stacks of optical sections taken with a Zeiss Apotome. (I’) Area indicated with
dashed box in (I). Scale bars: (E,G) 200 μm; (F,H) 40 μm; (I,I’)2 0μm. (J) Relative contribution of cells marked with Gli1-GIFM between E7.5 and
E9.5 to the SN, dlVTA and vmVTA; see schematic in Figure 6L. For each animal (n ≥ 3), TH-positive fate-mapped cells were counted in the three
indicated areas and normalized for the combined number of overlapping cells counted in these areas (in percent). Error bars indicate standard
deviation. Significance (*P < 0.05; **P < 0.01) was determined by ANOVA and LSD post-hoc analysis. (K) Fate mapping strategy. (L) Relative
contribution of fate-mapped cells to different rostral-caudal midbrain regions at E18.5. For each animal (n ≥ 3), b-gal- and TH-co-expressing cells
were counted in four rostral-caudal midbrain regions (see (M)) and normalized for the combined number of cells counted in the four regions (in
percent). Error bars indicate standard deviation. Significance (*P < 0.05; **P < 0.01) was determined by ANOVA and LSD post-hoc analysis. (M)
Rostral-caudal areas used to quantify the contribution of fate-mapped cells to DA neurons at E18.5. RRF, retrorubral field.
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Page 14 of 19and/or dendrites, cells with small cell bodies and a ‘halo’
of weakly labeled, small and highly branched processes
were detected within the SN and VTA areas (TM9.5, 19
of 21 sections; TM11.5, 19 of 19 sections; Figure 6C,F,H
and data not shown). Since the latter morphology is
indicative of astrocytes, we performed immunostainings
for b-gal and glutamine synthetase, an established broad
astrocyte marker [35,36] or for b-gal and the astrocyte
marker GFAP [37]. We found that b-gal-positive cells
with an astrocytic morphology indeed expressed gluta-
mine synthetase and GFAP (Figure 8B-D). Consistent
with the Shh-GIFM results, Gli1-derived cells labeled
with TM8.5 and TM9.5 also gave rise to cells with
astrocytic morphology (Figures 7D,F,H and 8A and data
not shown). Notably, cells with astrocytic morphologies
were less often observed in the DA neuron-containing
areas with Shh GIFM TM8.5 (astrocytes in 8 of 40 sec-
tions; Figure 6A,B,E,G and data not shown) or Gli1
GIFM TM7.5 (24 of 39 sections; data not shown), indi-
cating that the medial precursor population marked
with these GIFM schemes has a low gliogenic potential.
Discussion
By determining the fate of ventral midbrain cells arising
from progenitors that express either Shh or Gli1 at dif-
ferent developmental time points, we were able to estab-
lish a detailed quantitative assessment of the
contribution of distinct ventral progenitor domains to
different DA nuclei, RN neurons and astrocytes. We
show that progenitors marked with Shh-GIFM at E8.0
to E11.5 and with Gli1-GIFM at E7.5 to E9.5 give rise to
DA neurons. We further uncovered that lateral precur-
sors that are labeled with Shh-GIFM after E10.5
(TM10.5 and TM11.5) preferentially give rise to DA
neurons in the vmVTA. In light of birth-dating studies,
the shift in potential could be solely linked to a later
birthdate of vmVTA than SN DA neurons [34]. How-
ever, when we traced the fate of Gli1-expressing pro-
genitors, which are located lateral to the ventral midline
at earlier stages (TM9.5 Gli1-GIFM), we found that
these cells also had an increased potential to contribute
to DA neurons in the vmVTA. These results suggest
that the distinct developmental fate of the lateral pro-
genitors that we observed with Shh-GIFM at E11.5 and
Gli1-GIFM at E9.5 is due, at least in part, to an intrinsic
difference between medial and lateral progenitors in the
ventral midbrain. Indeed, factors such as Corin and
Msx1 appear to be more medially restricted within the
broad Lmx1a expression domain, which is thought to
give rise to all DA neurons (Figure 2A-H) [23,30]. Alter-
natively, our data could support a model in which DA
neurons in the vmVTA do not arise from the Lmx1a-
positive domain, but rather arise from the more lateral
Nkx6-1 domain. This idea is based on the observations
that only very few precursor cells are labeled within the
Lmx1a-positive domain with Gli1-GIFM at E9.5, but we
still find substantial contribution of the fate-mapped
cells to the vmVTA. Finally, Shh-a n dGli1-expressing
precursors that overlap with the lateral Lmx1a, Nkx6-1
and Nkx2-2 domains also give rise to ventral midbrain
astrocytes and RN neurons, but the most medially
located precursors that are labeled with Shh-GIFM at
E8.5 or Gli1-GIFM at E9.5 are much less gliogenic and
produce only few RN neurons. The ventral progenitor
Figure 8 Fate-mapped cells contribute to midbrain astrocytes.
(A-D) Immunostaining for glutamine synthetase (GS) and b-gal (A,B)
or GFAP and b-gal (C,D). Sections were imaged using a Zeiss
Apotome setup. (A,B) b-gal-positive cells with astrocytic morphology
overlap with GS. (C,D) Note that not all b-gal-positive cells with
astrocytic morphology express GFAP. Filled arrowheads indicate
cells that co-express GFAP; open arrowheads indicate cells that do
not express GFAP; arrows highlight cells with a neuronal
morphology. Scale bars: (A-B’’)1 0μm; (C-D’’)4 0μm.
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Page 15 of 19region of the mesencephalon thus has a higher degree of
complexity than was previously appreciated.
A recent GIFM study using Shh
CreERneo concluded
that progenitors from distinct medial-lateral domains
in the ventral mesencephalon give rise to DA and RN
neurons [9]. It was also proposed that different ventral
Shh-expressing progenitor domains might give rise to
distinct DA neurons [9]. In that study, three precursor
domains were delineated based on the location of fate-
mapped cells in the E10.5 to E13.5 mesencephalon: a
medial (TM7.5), a medial-lateral (TM8.0) and a lateral
(TM11.5 and TM12.5) domain. With TM7.5 Shh-
GIFM, that study observed b-gal-positive cells in the
vmVTA and in the overlying rostral linear nucleus at
E18.5. However, immunostaining for TH and b-gal
showed that very few fate-mapped cells were DA neu-
rons. Largely based on the distribution of b-gal-posi-
tive (X-gal-labeled) cells in E18.5 midbrain sections,
the authors further concluded that Shh-GIFM with
TM8.5 resulted in labeling of all subsets of DA neu-
rons, whereas precursors labeled with TM11.5 or
TM12.5 contributed to the RN and the vmVTA. How-
ever, the study did not identify which neuronal sub-
types expressed b-gal in the adult, and did not
distinguish between marked neurons and glia for most
labeling time points. Since we found that Shh-derived
astrocytes are intermingled with DA and RN neurons,
the distinction of different cell types is a prerequisite
for making qualitative and quantitative conclusions
about the contribution of fate-mapped cells to different
ventral midbrain cell types. Indeed, we also find that
medial cells are labeled in the anterior midbrain with
TM7.5, but only rarely do these cells express TH (data
not shown). Similarly, with TM11.5 we observed cells
i nt h ea r e ao ft h eR N ,b u tm a r k e ra n dm o r p h o l o g i c a l
analysis revealed that few fate-mapped cells expressed
Pou4f1 and most had an astrocytic morphology (Fig-
ures 4I,K and 6F,H and data not shown).
In addition to delineating different precursor pools,
the dissection of the fate of Shh-responding (Gli1-
expressing) and Shh-expressing cells provides new
insight into when Shh signaling might be required for
induction of DA and RN neurons. Gli1 expression is a
well-established readout for Shh signaling in the devel-
oping embryo, as Gli1 expression is dependent on acti-
vator functions of Gli2 and Gli3 [10,11]. While it cannot
be fully excluded that Gli1 transcription might also be
activated by other signaling pathways in some tissues or
tumors [38], we have previously shown that inactivation
of Shh signaling in the midbrain between E8.5 and E9.0
results in the rapid and complete loss of Gli1 expression
[13]. Based on the changing expression patterns of Shh
and Gli1 and our GIFM results, we propose the follow-
ing timeline for Shh signaling in the ventral midbrain
(compare Figure 2Z): a medial, largely Lmx1a-positive
progenitor domain gives rise predominantly to DA
neurons and receives only a brief high level of Shh sig-
naling from the underlying notochord around E8.0
(Gli1-GIFM at E7.5, domain 1). The progenitors in this
medial domain subsequently cease responding to Shh
(and stop expressing Gli1)o n c et h e ys t a r te x p r e s s i n g
Shh (Shh-GIFM at E8.5 and Gli1-GIFM at E9.5). Pro-
genitors in the adjacent domain that spans the lateral
Lmx1a domain, the Nkx6-1 domain and the medial
part of the Nkx2-2 domain receive a high level of Shh
signaling when Shh is induced in cells of the medial
floor plate after E8.5 (Gli1-GIFM at E8.5). Most of
these progenitors cease responding to Shh after E9.5
and switch on Shh expression (Gli1-GIFM at E9.5 and
Shh-GIFM at E9.5). Progenitors in the ventral-lateral
domain thus receive Shh signaling after E8.5 and they
give rise to DA neurons, RN neurons, oculomotor neu-
rons and astrocytes. Finally, progenitors in a more lat-
eral, Nkx2-2-positive domain only respond strongly to
Shh signaling after the lateral expansion of the Shh
expression domain (Gli1-GIFM at E9.5 and Shh-GIFM
at E9.5) and give rise to neurons in the SN reticularis.
Surprisingly, some cells in the Lmx1a and Nkx6-1-
positive domain in the posterior midbrain sustain their
ability to respond to Shh signaling after E9.5, indicat-
ing that the switch from Shh-responsiveness to Shh-
expression might not be an all-or-nothing event in
some cells, or occurs in a progressive manner from
anterior to posterior. A gradual switch is supported by
the RNA in situ hybridization data, which show that,
at E9.5, weak/mosaic Shh expression at the lateral edge
of the Shh domain partially overlaps with weak/mosaic
Gli1 expression at the medial edge of the Gli1 domain
(Figure 1B,G). Interestingly, even though Shh is even-
tually downregulated medially, medial progenitors do
not initiate a second high-level response to Shh signal-
ing, as judged by the absence of medial Gli1 expression
at E11.5 and E12.5 (Figure 1). The temporally dynamic
expression and signaling of Shh in the mesencephalon
we describe here is distinct from the classical morpho-
g e nm o d e lo fS h hi nt h es p i n a lc o r d ,w h e r en e u r o n a l
progenitor cells are continuously exposed to Shh and
interpret the Shh signal based on the concentration
and duration of Shh signaling [39]. The model is, how-
ever, consistent with the recently proposed mechan-
isms for the induction of the floor plate in the spinal
cord, which is based on a changing response of floor
plate precursors to Shh signaling. Initially, the induc-
tion of spinal cord floor plate identity requires high
levels of Shh signaling from the underlying notochord.
Subsequently, in order to establish full floor plate iden-
tity, the precursors must cease responding to Shh sig-
naling by extinguishing Gli2 and Gli3 expression [40].
Blaess et al. Neural Development 2011, 6:29
http://www.neuraldevelopment.com/content/6/1/29
Page 16 of 19Is our proposed model of Shh signaling supported by
studies of loss-of-function in components of the Shh
pathway? Complete inactivation of Shh signaling in Shh
null mutants results in the loss of all ventral midbrain
structures [13,41]. Thus, Shh signaling is essential for
DA, RN and motoneuron induction. Using conditional
knock-out analysis to inactivate Shh signaling by delet-
ing the Shh receptor Smoothened (Smo)i nt h em i d /
hindbrain at different time points, we previously showed
that some DA neurons only require Shh signaling before
E9.0, since a small number of DA neurons are induced
when Shh signaling is inactivated at E9.0. In contrast,
inactivation of Shh signaling at E11.0 has no effect on
the specification of DA neurons [13]. It was further
demonstrated that Islet1-positive motoneurons are com-
pletely lost when Smo or Shh are inactivated at E9.0 in
the mid/hindbrain [13,42]. Consistent with these pre-
vious findings, our present fate-mapping data show that
Shh-responding (Gli1-expressing) progenitors contribute
to DA neurons only before E10.5 (TM7.5 to TM9.5)
and to oculomotor neurons after E8.5 (TM8.5).
Given the finding that progenitors lateral to the ventral
midline that are labeled with Shh-GIFM at E11.5 or Gli1-
GIFM at E9.5 preferentially give rise to vmVTA DA neu-
rons and therefore have a more restricted fate potential
than progenitors in the ventral midline, it is tempting to
speculate that intrinsic molecular differences in spatially
segregated DA progenitor populations are causally linked
to the distinct physiological and functional properties of
the DA neurons they give rise to. For example, DA neu-
rons that project to corticolimbic targets are primarily
located in the vmVTA and have unconventional fast-fir-
ing properties and small dopamine transporter/TH
mRNA expression ratios. In contrast, SN DA neurons
and dlVTA DA neurons project to the dorso-lateral stria-
tum and the lateral shell of the nucleus accumbens,
respectively, and have slow-firing properties and a high
dopamine transporter/TH mRNA expression ratio [43].
Conclusions
Our study provides a spatial-temporal genetic fate map
of the ventral mesencephalic precursors based on the
dynamic expression of Shh and Gli1.S i n c eGli1 expres-
sion is a readout for Shh signaling, our GIFM analysis
also gives insight into when and where different ventral
midbrain progenitors receive high levels of Shh signaling
and suggests that the timing and duration of Shh signal-
ing might influence the type of DA neuron a particular
progenitor becomes. In conclusion, our study establishes
a direct link between the location, distinct gene expres-
sion and Shh-responsiveness of ventral midbrain precur-
sors and the fate of their descendants in the adult
murine midbrain.
Additional material
Additional file 1: Comparison of the extent of labeling using the
Shh
CreERneoand Shh
CreERalleles with R26
lzreporter mice. Coronal
sections of E18.5 brains were labeled with X-gal staining and
counterstained with Fast Red. TM (4 mg) was given at E10.5. (A-F) Note
that only few cells are labeled in the midbrain of Shh
CreERneo/+R26
lz/+ mice
(A-C), while many cells are labeled in the midbrain of Shh
CreER/+R26
lz/+
mice (D-F). Pictures in the upper right corner are higher magnifications
of the area indicated in the black box. Several images were taken for
each area shown and stitched together using the Zeiss Mosaix software.
Additional file 2: Initial domains of cells marked with Shh- or Gli1-
GIFM in comparison with Lmx1a. (A-H’) TM was administered at the
indicated time points and marked cells were analyzed at E12.5 on
anterior and posterior coronal midbrain sections with EYFP (red) and
Lmx1a (green) immunostaining. Note that on anterior sections there is
no or only little overlap of Lmx1a with cells fate-mapped with Shh-GIFM
at E11.5 or Gli1-GIFM at E9.5. Scale bars: (A-H) 100 μm; (B’,D’,F’,H’)5 0μm.
(I-L) Number of fate-mapped cells overlapping with Lmx1a (I,K) or TH (J,
L). Cells were counted on one anterior (ant), one intermediate (int) and
one posterior (pos) coronal section for each E12.5 embryo (or at E11.5 for
Shh-GIFM TM8.5). For one time point and one section level, each data
point represents cell numbers from one embryo. Note that overlap of
fate-mapped cells is much higher with Lmx1a than with TH, since Lmx1a
is expressed in DA precursors and differentiated DA neurons and
differentiation of DA neurons is not complete by E12.5. The trends
observed at E12.5 correlate with the results of the analysis at E18.5 and
in the adult brain sections: the highest contribution to DA neurons is
observed with Shh-GIFM at E9.5 (I,J); cells marked with Shh-GIFM TM8.5
contribute preferentially to anterior DA neurons (J); cells marked with
Shh-GIFM TM11.5 contribute preferentially to intermediate and posterior
DA neurons (J); Gli1-GIFM results in less labeling than Shh-GIFM
(compare (I,J) with (K,L)).
Additional file 3: Markers used to determine the location of Shh-
and Gli1-derived precursors in relation to known ventral midbrain
expression domains.
Additional file 4: Contribution of fate-mapped cells to different
regions of DA neurons along the rostral-caudal axis of the prenatal
midbrain and to different subsets of DA neurons in the adult
midbrain. (A,B) Number of Shh-derived (A) or Gli1-derived (B) cells
contributing to different rostral-caudal regions of DA neurons at E18.5.
For each animal (n ≥ 3), b-gal- and TH-co-expressing cells were counted
in four regions along the rostral-caudal axis of the ventral midbrain as
indicated in Figure 5B and normalized for the number of sections
counted for each region. (C,D) Number of Shh-derived (C) or Gli1-
derived (D) cells contributing to different subsets of DA neurons in the
adult brain. For each animal (n ≥ 3), b-gal- and TH-co-expressing cells
were counted in the SN, dlVTA and vmVTA as indicated in Figure 6L and
normalized for the number of sections counted for each region. (E,F)
Relative distribution of DA neurons in the SN, dlVTA and vmVTA (black
bars) compared to the relative contribution of Shh-GIFM marked cells to
the three areas. For a clearer representation, the data were split into two
diagrams. The data for the fate-mapped cells (TM8.5, TM9.5, TM10.5,
TM11.5) are also shown in Figure 6I. Error bars indicate standard
deviation. Significance (*P < 0.05; **P < 0.01; ***P < 0.001) was
determined by ANOVA and LSD post-hoc analysis (A-D) or Student’s t-
test (E,F).
Abbreviations
ANOVA: analysis of variance; β-gal: β-galactosidase; DA: dopaminergic; dlVTA:
dorsal-lateral VTA; E: embryonic day; EYFP: enhanced yellow fluorescent
protein; GFAP: glial fibrillary acidic protein; GFP: green fluorescent protein;
GIFM: genetic inducible fate mapping; LSD: least significant difference; P:
postnatal day; RN: red nucleus; Shh, Sonic Hedgehog; SN: substantia nigra;
TH: tyrosine hydroxylase; TM: tamoxifen; vmVTA: ventral-medial VTA; VTA:
ventral tegmental area.
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